Alvotech Stock Performance
| ALVO Stock | USD 11.34 0.03 0.27% |
The firm shows a Beta (market volatility) of 0.13, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Alvotech's returns are expected to increase less than the market. However, during the bear market, the loss of holding Alvotech is expected to be smaller as well. At this point, Alvotech has a negative expected return of -0.0879%. Please make sure to confirm Alvotech's value at risk, as well as the relationship between the skewness and day median price , to decide if Alvotech performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Alvotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Alvotech is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors. ...more
Actual Historical Performance (%)
One Day Return 0.27 | Five Day Return 0.62 | Year To Date Return (13.83) | Ten Year Return 1.34 | All Time Return 1.34 |
1 | Are Medical Stocks Lagging Alvotech This Year | 12/30/2024 |
2 | Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for AVT05, a Proposed Biosimilar to Simponi and Simponi Aria | 01/27/2025 |
3 | Alvotech Sees Significant Growth in Short Interest | 01/28/2025 |
4 | Alvotech and Teva Announce Filing Acceptance ofU.S. Biologics License Application for AVT06,a Proposed Biosimilar to Eylea | 02/18/2025 |
5 | Teva and Alvotech Announce SELARSDI Injectio | 02/21/2025 |
6 | Alvotech Shares Up 5.5 percent - Time to Buy - MarketBeat | 02/25/2025 |
7 | Alvotech to Participate in Barclays 27th Annual Global Healthcare Conference | 03/07/2025 |
8 | Alvotech Short Interest Update - Defense World | 03/13/2025 |
| Begin Period Cash Flow | 66.4 M |
Alvotech |
Alvotech Relative Risk vs. Return Landscape
If you would invest 1,211 in Alvotech on December 19, 2024 and sell it today you would lose (77.00) from holding Alvotech or give up 6.36% of portfolio value over 90 days. Alvotech is currently does not generate positive expected returns and assumes 2.1812% risk (volatility on return distribution) over the 90 days horizon. In different words, 19% of stocks are less volatile than Alvotech, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Alvotech Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Alvotech's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Alvotech, and traders can use it to determine the average amount a Alvotech's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0403
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ALVO |
Estimated Market Risk
| 2.18 actual daily | 19 81% of assets are more volatile |
Expected Return
| -0.09 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Alvotech is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Alvotech by adding Alvotech to a well-diversified portfolio.
Alvotech Fundamentals Growth
Alvotech Stock prices reflect investors' perceptions of the future prospects and financial health of Alvotech, and Alvotech fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Alvotech Stock performance.
| Return On Asset | -0.0104 | ||||
| Profit Margin | (1.12) % | ||||
| Operating Margin | 0.12 % | ||||
| Current Valuation | 4.47 B | ||||
| Shares Outstanding | 301.94 M | ||||
| Price To Sales | 8.67 X | ||||
| Revenue | 91.43 M | ||||
| Gross Profit | 232.52 M | ||||
| EBITDA | (484.86 M) | ||||
| Net Income | (551.73 M) | ||||
| Cash And Equivalents | 128.44 M | ||||
| Cash Per Share | 0.52 X | ||||
| Total Debt | 1.08 B | ||||
| Current Ratio | 0.86 X | ||||
| Book Value Per Share | (1.22) X | ||||
| Cash Flow From Operations | (312.19 M) | ||||
| Earnings Per Share | (1.85) X | ||||
| Market Capitalization | 3.41 B | ||||
| Total Asset | 950.09 M | ||||
| Retained Earnings | (2.21 B) | ||||
| Working Capital | (66.11 M) | ||||
About Alvotech Performance
By examining Alvotech's fundamental ratios, stakeholders can obtain critical insights into Alvotech's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Alvotech is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 194.23 | 316.75 | |
| Return On Tangible Assets | (0.69) | (0.72) | |
| Return On Capital Employed | (0.59) | (0.62) | |
| Return On Assets | (0.67) | (0.70) | |
| Return On Equity | 0.53 | 0.49 |
Things to note about Alvotech performance evaluation
Checking the ongoing alerts about Alvotech for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Alvotech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Alvotech generated a negative expected return over the last 90 days | |
| Alvotech has a very high chance of going through financial distress in the upcoming years | |
| Alvotech currently holds 1.08 B in liabilities. Alvotech has a current ratio of 0.84, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Alvotech's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 91.43 M. Net Loss for the year was (551.73 M) with profit before overhead, payroll, taxes, and interest of 232.52 M. | |
| Alvotech currently holds about 128.44 M in cash with (312.19 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.52. | |
| Roughly 65.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Alvotech Short Interest Update - Defense World |
- Analyzing Alvotech's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Alvotech's stock is overvalued or undervalued compared to its peers.
- Examining Alvotech's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Alvotech's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Alvotech's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Alvotech's stock. These opinions can provide insight into Alvotech's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alvotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. To learn how to invest in Alvotech Stock, please use our How to Invest in Alvotech guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alvotech. If investors know Alvotech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alvotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.70) | Earnings Share (1.85) | Revenue Per Share | Quarterly Revenue Growth 4.786 | Return On Assets |
The market value of Alvotech is measured differently than its book value, which is the value of Alvotech that is recorded on the company's balance sheet. Investors also form their own opinion of Alvotech's value that differs from its market value or its book value, called intrinsic value, which is Alvotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alvotech's market value can be influenced by many factors that don't directly affect Alvotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alvotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alvotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alvotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.